Gelteq (GELS), a biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, priced its initial public offering of 1.3M ordinary shares at a price of $4.00 per share. The shares are listed on the Nasdaq under the symbol “GELS.” Benchmark is acting as the lead managing underwriter for the offering.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off